Antibacterial agent 150 , CAS No.A1416670

CAS: A1416670 Cat. No.: A1416670 Summenformel: C33H45NO6 Molekulargewicht: 551.71
Zu bestellen verfügbar
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1mg
A1416670-1mg
Auf Bestellung · 8–12 Wochen
Enter a quantity for the sizes you want to add.

Übersicht

Antibacterial agent 150 (compound 5g) is an antibacterial agent with potent antibacterial activity against both Gram-positive bacteria and Gram-negative bacteria (MIC values ranging from 1-32 μg/mL). Antibacterial agent 150 can increase survival rate of MRSA (Methicillin-resistant Staphylococcus aureus )-infected mice.

Spezifikationen

Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Aktionsart
INHIBITOR
Namen und Kennungen
Molekulargewicht
551.71

Erweiterte Daten

Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

No tested application protocols are provided in the Product Data for Antibacterial agent 150. The following are general research workflows and should be adapted to your laboratory’s SOPs and the compound’s confirmed properties.

General MIC assay setup (broth microdilution; not item-specific):

  • Prepare a 10–20 mM DMSO stock; confirm solubility and clarity.
  • Perform 2-fold serial dilutions across microplate wells in cation-adjusted Mueller–Hinton broth, keeping DMSO constant (≤1% v/v).
  • Inoculate with standardized bacterial suspension (e.g., 5×10^5 CFU/mL), incubate 16–20 h at 35 ± 2 °C.
  • Read OD600 or use resazurin/ATP luminescence; define MIC as the lowest concentration with no visible growth.

Cytotoxicity counterscreen (eukaryotic cells; not item-specific):

  • Assess cell viability in parallel using resazurin/CellTiter-type assays to gauge selectivity.

Data management:

  • Record lot number, plate layout, controls (vehicle, growth, positive antibiotic controls), and environmental conditions.

Note: These are generic research methods. Aladdin Scientific provides this product for research use only; consult your institutional biosafety and QA requirements.

Biological Roles

Item-specific biological targets or modes of action are not provided for Antibacterial agent 150. Therefore, no definitive biological role can be assigned to this specific compound from the Product Data alone.

General context for antibacterial screening compounds (literature/practice; not item-specific):

  • Putative roles: Such molecules are typically assessed for their ability to inhibit bacterial growth, biofilm formation, or specific bacterial enzymes or pathways.
  • Potential pathways commonly interrogated: Cell wall biosynthesis (e.g., PBPs, Mur family enzymes), DNA replication (DNA gyrase/topoisomerase IV), transcription/translation machinery, fatty acid biosynthesis, and membrane integrity.
  • Assay readouts: Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), time–kill kinetics, and reporter-based phenotypes (e.g., membrane depolarization dyes).
  • Resistance profiling: Selection of spontaneous resistant mutants and whole-genome sequencing can link phenotypes to targets or transport/resistance mechanisms.

Caveats:

  • Off-target effects and assay artifacts (e.g., aggregation, redox cycling, fluorescence interference) can mimic antibacterial activity; deploy orthogonal assays, include detergent controls for aggregators, and monitor compound stability.
  • No pharmacological or clinical conclusions should be drawn from catalog designation alone. All testing must be conducted under controlled research conditions with appropriate controls.
Buffer Applications

This product is a discrete small molecule intended for screening and is not a buffering agent. No buffer-capacity parameters or pKa values are provided for Antibacterial agent 150.

Guidance for use with buffers (general, not item-specific):

  • Prepare master stocks in DMSO and dilute into microbiological media (e.g., CAMHB, MHB2) or biochemical assay buffers to reach the desired final concentration while keeping DMSO ≤0.5–1% v/v.
  • If precipitation occurs on dilution, consider a co-solvent approach (e.g., 2–5% DMSO) or adjust ionic strength/pH based on the compound’s ionization profile once known.
  • Filter sterilize working solutions only if the compound is confirmed to be filter-stable and sufficiently soluble; otherwise prepare aseptically from sterile stocks.

Item-specific buffer properties (pKa ranges, buffer recipes, compatibility): Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

Because Antibacterial agent 150 is a discrete library compound rather than a process solvent or commodity reagent, “green alternatives” relate mainly to the choice of vehicle and workup solvents during assay preparation and analytical handling.

General solvent considerations (not item-specific):

  • Prefer water-based buffers with minimal DMSO (≤0.5–1% v/v) when biologically feasible to reduce organic solvent use.
  • For chromatographic and preparative work, consider ethanol or isopropanol in place of acetonitrile where method performance allows.
  • Avoid high-toxicity polar aprotics (e.g., NMP, DMF) in routine assay contexts; limit use to minimal volumes if necessary.

Illustrative comparison (general guidance):

  • DMSO vs DMF: DMSO offers broad solvency with comparatively lower toxicity; DMF can be avoided unless required for difficult solutes.
  • MeOH/MeCN vs EtOH/i-PrOH: EtOH/i-PrOH are generally preferred from a green chemistry perspective but may affect assay sensitivity and evaporation rates.

Operational best practices:

  • Aliquot stocks to minimize freeze–thaw and waste.
  • Use microvolume dispensing and sealed plates to curb evaporation and emissions.
  • Implement miniaturized assays (e.g., 384/1536-well) to reduce overall solvent consumption.

Always balance green choices with assay fidelity, compound stability, and safety requirements.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation-use information is provided for Antibacterial agent 150. It is supplied strictly for research use only and is not for human or veterinary use.

General guidance (not item-specific):

  • Screening compounds with antibacterial designations may serve as tool molecules in pre-formulation research to assess solubility, permeability, stability, and preliminary compatibility with excipients. Such activities remain strictly non-clinical.
  • If formulation-like studies are pursued in research, typical vehicles include DMSO, PEG-containing systems, or cyclodextrin solubilizers; compatibility and stability must be verified experimentally.

Do not infer any clinical application, dosage form suitability, or regulatory compliance from the catalog name. For any translational work, comprehensive CMC characterization, toxicology, and regulatory pathways are required—outside the scope of this research-grade material.

Physical Properties

Item-specific physical constants are not provided in the Product Data for Antibacterial agent 150. Do not assume values; consult the CoA/Spec Sheet for authoritative specifications.

Item-specific status:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point / Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density / Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa / logP / logD: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/practice; not item-specific):

  • Stock preparation: For diverse screening compounds, DMSO (anhydrous) is the most common solvent for 10–20 mM master stocks due to broad solvency and assay compatibility at ≤1% v/v in wells.
  • Aqueous handling: If aqueous work is required, co-solvent systems (e.g., DMSO:buffer 1:9) or surfactant-assisted solutions (0.01–0.05% Tween 80) are sometimes used in screening contexts; verify compound compatibility.
  • Hygroscopicity/Photolability: Unknown for this item; handle under low moisture and subdued light until data are confirmed.
  • Particle handling: If supplied as a solid, gentle warming (≤40 °C) and vortex/sonication can aid dissolution; avoid prolonged heating without confirmed stability.

Always refer to the product’s CoA/SDS for precise physical and compatibility data before use.

Quality and Grades

No explicit grade or purity values are provided in the Product Data for Antibacterial agent 150. Do not infer analytical or chromatographic grade without documentation.

Item-specific notes:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/Antioxidants: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret grades (general guidance):

  • Screening Library/Discovery-Grade: Typically intended for target or phenotypic screening. Purity is often ≥90% by HPLC/LC–MS, but the definitive threshold varies by supplier—confirm with CoA. Low water and residual solvent levels are preferred for assay reliability.
  • Analytical/HPLC Grade: Applies to solvents/reagents formulated for low UV background and minimal trace impurities; not usually applicable to discrete small molecules.
  • Pharmacopoeial Grade (USP/EP/JP): Not applicable here unless explicitly stated (none provided).

Data you may request for this item:

  • HPLC/UPLC purity and chromatogram (detection wavelength(s) and methods)
  • LC–MS/HRMS identity confirmation
  • NMR (1H, 13C) and IR spectra
  • Water content (KF), residual solvents (GC)
  • Inorganic residue/metals (if relevant)

Recommendation: For structure-activity work, request a CoA with batch-specific purity, identity, and assay-relevant notes (salt form, polymorph, counterions).

Reaction and Applications

This item is cataloged as a small-molecule “Antibacterial agent” for research screening rather than as a synthetic reagent. Consequently, its primary application is in discovery biology and chemical biology workflows rather than in facilitating chemical transformations.

Research applications (general, not item-specific):

  • Phenotypic antibacterial screening: Evaluate growth inhibition across Gram-positive/Gram-negative panels (e.g., MIC assays in broth microdilution) with standardized vehicle controls.
  • Target-based assays: If a bacterial target is defined in your project (e.g., DNA gyrase, MurA, PBPs), test enzyme inhibition with appropriate substrates and orthogonal readouts (fluorescence, absorbance, LC–MS).
  • SAR development: Use this compound as a probe/hit candidate; follow up with analog profiling, orthogonal assays, and resistance mapping.
  • Combination studies: Examine additivity/synergy using checkerboard or Bliss independence analyses against reference antibiotics to infer MoA interactions.

Chemical reactivity: Not specified for this item; structure and functional groups are unknown.

Practical execution:

  • Prepare DMSO master stocks; confirm assay compatibility at the working solvent percentage.
  • Include positive controls (e.g., ciprofloxacin, vancomycin) and sterility controls.
  • Track lot numbers and maintain detailed plate maps to ensure reproducibility.

For any synthetic use, obtain the structure and reactivity profile from the CoA before attempting transformations.

Reaction Conditions

No reaction chemistry or transformation conditions are specified for Antibacterial agent 150, and its structure is undisclosed. As such, recommended reaction conditions cannot be provided for this particular item.

General guidance if synthetic modification is contemplated after structure disclosure (literature/practice; not item-specific):

  • Cross-coupling (Suzuki, Buchwald–Hartwig, Sonogashira): Typical Pd catalysts (e.g., Pd2(dba)3/XPhos; Pd(OAc)2/SPhos) in toluene/1,4-dioxane/THF or aqueous mixed media; bases like K3PO4, Cs2CO3; 60–110 °C.
  • Amide coupling: EDCI/HOBt, HATU, or T3P in DMF/DCM/MeCN; DIPEA or NMM; 0–25 °C to room temperature.
  • Reductive amination: NaBH3CN or BH3·THF with aldehyde/ketone partners in MeOH/THF; careful quench and pH control.
  • Heteroaromatic N-oxidation/reduction, SNAr, or nucleophilic additions: Solvent/base and temperature highly substrate-dependent.

For biological assay preparation (applicable, not a chemical reaction):

  • Prepare 10–20 mM DMSO master stocks, verify clarity, aliquot, store at −20 °C.
  • Dilute into assay media maintaining constant vehicle percentage; include precipitation checks and control wells.

Definitive reaction conditions for this specific item are unavailable—consult the CoA and structural dossier before planning any transformations.

Safety and Handling

Hazard classifications are not specified in the Product Data for this item. Implement prudent laboratory precautions for unknown small molecules and defer to the product SDS for authoritative guidance.

Item-specific safety data:

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.

General safe-handling practices (good laboratory practice for screening compounds):

  • PPE: Wear lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Consider double-gloving for DMSO solutions to limit dermal uptake.
  • Engineering controls: Work in a certified chemical fume hood, especially during weighing, dissolution, or when heating/sonicating solutions.
  • Avoid exposure routes: Prevent inhalation of dust/aerosols and skin/eye contact. Use dust-minimizing techniques when handling powders.
  • Incompatibilities: Unknown for this item; segregate from strong oxidizers/reductants and acids/bases until confirmed. Avoid reactive metals if the structure is unknown.
  • Spill/cleanup: Absorb liquid spills with inert material; for solids, dampen to avoid dust, then collect into a sealable container for disposal. Decontaminate surfaces with suitable solvent followed by detergent/water.
  • First aid (overview): Move exposed persons to fresh air; rinse skin/eyes with water for at least 15 minutes; seek medical attention. Provide SDS to responders.
  • Waste: Collect in an organic hazardous waste stream. Do not discharge to drains.

Always consult the specific SDS supplied with the lot before use.

Solvent Selection

Item-specific solubility data are not provided. Choose solvents based on general best practices for screening compounds, and verify with a small-scale solubility check.

Most common primary solvent (practice-based):

  • DMSO (anhydrous) — broad solvency across drug-like chemical space; compatible with most biochemical and cell-based assays at ≤0.5–1% v/v.

Secondary options (verify compatibility):

  • DMF or NMP: Useful for stubborn solutes; consider cytotoxicity in biological assays and handle with care.
  • Ethanol or methanol: Generally assay-compatible at low percentages; may impact membrane permeability/viability—perform controls.
  • Aqueous buffers: Feasible if the molecule is sufficiently polar/ionizable; co-solvent strategies (e.g., 5–10% DMSO) can help.

Small comparison (general, not item-specific):

  • DMSO: Highest solvency; potential to enhance dermal uptake—use proper gloves.
  • MeOH/EtOH: Lower solvency but easier evaporation and lower viscosity.
  • DMF/NMP: Powerful solvents; consider higher toxicity and extraction of plastics.

Practical tips:

  • Prepare a 10–20 mM master stock in DMSO, filter if soluble (PTFE or hydrophobic PVDF), aliquot, and store at −20 °C to minimize freeze–thaw.
  • Assess solubility visually and by nephelometry or light scattering where possible.
  • Maintain consistent vehicle controls (same solvent and percentage) across assays.
Storage and Reconstitution

Item-specific conditions (from Product Data):

  • Storage: Store at −20 °C.
  • Shipment: Ice chest + ice pads.

Additional practical guidance (general best practice for small-molecule screening compounds):

  • Reconstitution solvent: If solubility data are absent, begin with anhydrous DMSO to prepare a 10–20 mM master stock. If insoluble, evaluate DMF or mixed DMSO:DMF while considering assay compatibility.
  • Aliquoting: Divide into single-use aliquots (e.g., 10–50 µL) in inert, low-bind tubes or sealed microplates to minimize freeze–thaw cycles and adsorption.
  • Freeze–thaw: Limit to ≤3 cycles. Thaw at ambient temperature, vortex briefly, and inspect for precipitation or discoloration.
  • Light/moisture: Protect from light and moisture until the compound’s stability profile is known (store in amber vials, desiccated secondary containment).
  • Aqueous dilutions: Prepare immediately before use; keep DMSO at a consistent final percentage across all wells/samples. Discard if precipitation or turbidity occurs.
  • Documentation: Record lot number, preparation date, solvent, concentration, and storage location on each aliquot.

For definitive stability, solubility, and concentration limits, consult the lot-specific CoA and SDS.

Structure and Identity

This product is supplied as an unnamed, cataloged small-molecule screening member designated “Antibacterial agent 150.” No definitive structural identifiers are provided in the Product Data.

Item-specific facts (from Product Data):

  • SKU: A1416670
  • Product Name: Antibacterial agent 150
  • CAS: A1416670 (internal/catalog reference; not a public CAS Registry Number)
  • Storage: Store at −20 °C
  • Shipment: Ice chest + ice pads
  • Intended use: For research use only

Structural identifiers for this item:

  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES / InChI / InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

General notes (context, not item-specific):

  • “Antibacterial agent” naming in screening libraries typically denotes a discrete, drug-like small molecule with plausible antibacterial activity in phenotypic or target-based assays. Such entries often include heteroatoms (N, O, S) and aromatic/heteroaromatic motifs common to bioactive scaffolds.
  • Without explicit identifiers, stereochemistry, ring systems, and functional groups cannot be asserted for this specific item. Request the Certificate of Analysis (CoA) or Structure Sheet from Aladdin Scientific for definitive identity, purity, and spectral data.
Synthetic Utility

Antibacterial agent 150 is presented as a finished small molecule for biological screening rather than as a synthetic intermediate. Without structure disclosure, its functional group content and reactivity cannot be described.

General considerations (not item-specific):

  • If structural information becomes available, evaluate handle groups (e.g., aryl halides, boronates, amines, acids, nitriles) for diversification via cross-coupling (Suzuki, Buchwald–Hartwig), amide coupling, reductive amination, or late-stage C–H functionalization.
  • For SAR campaigns, common modifications include heteroaromatic swaps, alkyl/aryl substitutions, bioisosteres (e.g., tetrazole for carboxylate), and solubilizing side chains. Protecting-group strategies and stability-indicating analytics (LC–MS, UPLC) support rapid iteration.
  • When unknown stability is a concern, avoid strong acids/bases, high temperatures, and radical conditions until the core’s robustness is established.

Recommendation: Obtain the CoA/structure sheet. If suitable reactive handles exist, the compound may serve as a lead for analog synthesis; otherwise, it should be treated as a reference standard or probe compound for biological assays.

Target Specificity

Target specificity is not provided for Antibacterial agent 150 in the Product Data. No specific bacterial pathway, enzyme, or molecular target is claimed for this item.

Item-specific target data:

  • Not specified for this item; refer to CoA/Spec Sheet or screening results generated in your laboratory.

General considerations (not item-specific):

  • Determine specificity via enzyme panels, resistant mutant mapping, chemical-genetic interaction profiling, or omix-based responses (transcriptomics/proteomics) following exposure.
  • Rule out PAINS and aggregator behavior using orthogonal assay formats, detergent controls, and concentration–response curve quality metrics (e.g., Hill slopes, assay window).

Häufig gestellte Fragen

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is A1416670, the molecular formula is C33H45NO6, and the molecular weight is 551.71 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.